E-LIB Suche - Ergebnisse für: Laforêt, P.

1

Pulmonary vascular resistance in patients with neuromuscula..:

Fayssoil, A. ; Béhin, A. ; Wahbi, K....
Archives of Cardiovascular Diseases. 117 (2024) 1 - p. S44 , 2024

Link: https://doi.org/10.1016/..

2

Epidemiology of myasthenia gravis in France: A retrospectiv..:

Salort-Campana, E. ; Laforet, P. ; de Pouvourville, G....
Revue Neurologique. 180 (2024) 3 - p. 202-210 , 2024

Link: https://doi.org/10.1016/..

3

P373 Effect size analysis of cipaglucosidase alfa + miglust..:

Diaz-Manera, J. ; Bratkovic, D. ; Byrne, B....
Neuromuscular Disorders. 33 (2023) - p. S151 , 2023

Link: https://doi.org/10.1016/..

4

Gene therapy review: Duchenne muscular dystrophy case study:

Berling, E. ; Nicolle, R. ; Laforêt, P..
Revue Neurologique. 179 (2023) 1-2 - p. 90-105 , 2023

Link: https://doi.org/10.1016/..

5

Progress in hereditary neuropathies, myopathies and motoneu..:

Camdessanché, J.-P. ; Laforêt, P.
Revue Neurologique. 179 (2023) 1-2 - p. 3-4 , 2023

Link: https://doi.org/10.1016/..

6

Prognosis of right ventricular systolic dysfunction in Duch..:

Orlikowski, D. ; Mansencal, N. ; Nguyen, S.L....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 50 , 2023

Link: https://doi.org/10.1016/..

7

P70 What are the priorities of adolescents and adults with ..:

Hogrel, J. ; Berling, E. ; Prigent, H....
Neuromuscular Disorders. 33 (2023) - p. S134 , 2023

Link: https://doi.org/10.1016/..

8

Prediction of cardiac outcomes in 600 adult patients with m..:

Savvatis, K. ; Vissing, C. ; Klouvi, L....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 30 , 2023

Link: https://doi.org/10.1016/..

9

P351 Rhabdomyolysis and muscle biopsy outcomes: a single ce..:

Ferreira, W. ; Massaro, C. ; Masingue, M....
Neuromuscular Disorders. 33 (2023) - p. S183 , 2023

Link: https://doi.org/10.1016/..

10

O21 104-week efficacy and safety of cipaglucosidase alfa+mi..:

Mozaffar, T. ; Bratkovic, D. ; Byrne, B....
Neuromuscular Disorders. 33 (2023) - p. S191 , 2023

Link: https://doi.org/10.1016/..

11

The new horizons for treatment of Late-Onset Pompe Disease ..:

Guémy, C. ; Laforêt, P.
Revue Neurologique. 179 (2023) 1-2 - p. 81-89 , 2023

Link: https://doi.org/10.1016/..

12

P69 Scoping review on the assessment tools used on SMA adol..:

Hogrel, J. ; Barrière, A. ; Bonnyaud, C....
Neuromuscular Disorders. 33 (2023) - p. S133-S134 , 2023

Link: https://doi.org/10.1016/..

13

Nusinersen treatment in adults with severe spinal muscular ..:

Lefeuvre, C. ; Brisset, M. ; Sarlon, M....
Revue Neurologique. 178 (2022) 3 - p. 234-240 , 2022

Link: https://doi.org/10.1016/..

14

VP.34 Two-year follow-up of muscle strength and function in..:

Decostre, V. ; Masingue, M. ; Laforêt, P....
Neuromuscular Disorders. 32 (2022) - p. S78 , 2022

Link: https://doi.org/10.1016/..

15

SMA – OUTCOME MEASURES AND REGISTRIES:

de la Banda, M. Gomez Garcia ; Grimaldi-Bensouda, L. ; Urtizberea, J....
Neuromuscular Disorders. 31 (2021) - p. S130-S131 , 2021

Link: https://doi.org/10.1016/..